Research

For the most up to date list of publications, check out my Google Scholar page.

Peer-reviewed Publications

  1. DD Sjoberg (2022). “Dcurves: decision curve analysis for model evaluation.” R package version, 0.3. 0 537

  2. DD Sjoberg, T Fei (2022). “tidycmprsk: competing risks estimation.” R package version, 0.2. 0 19

  3. DD Sjoberg, K Whiting, M Curry, JA Lavery, J Larmarange (2021). “Reproducible summary tables with the gtsummary package.” The R journal, 13 (1), 570-580

  4. DD Sjoberg, K Whiting, M Curry, J Lavery, J Larmarange (2021). “Reproducible summary tables with the gtsummary package. R J. 13, 570–580.” ,

  5. DD Sjoberg, M Curry, M Hannum, K Whiting, EC Zabor (2020). “gtsummary: Presentation-ready data summary and analytic result tables.” R package version, 1 (2)

  6. DD Sjoberg, M Curry, M Hannum, J Larmarange, K Whiting, EC Zabor, and others (2020). “Gtsummary: Presentation-ready data summary and analytic result tables. 2020.” URL https://CRAN. R-project. org/package= gtsummary. R package version, 1 (5 …

  7. DD Sjoberg, M Curry, M Hannum, K Whiting, EC Zabor (2020). “gtsummary: Presentation-ready data summary and analytic result tables. R package version 1.3. 5.” ,

  8. DD Sjoberg, M Curry, M Hannum, K Whiting, EC Zabor, E Drill (2020). “gtsummary: Presentation-ready data summary and analytic result tables [Internet]; 2020.” ,

  9. DD Sjoberg, AJ Vickers, M Assel, A Dahlin, BY Poon, D Ulmert, H Lilja (2018). “Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men.” European urology, 73 (6), 941-948

  10. DD Sjoberg (2014). “Toward a smarter prostate cancer screening program..” European Urology, 68 (4), 598-599

  11. DD Sjoberg (2005). “Coherent effects in single scattering and random errors in antenna technology.” Progress In Electromagnetics Research, 50, 13-39

  12. DD Sjoberg (2001). “Transient Electromagnetic Waves in Nonlinear Media.” ,

  13. JA Coleman, W Yip, NC Wong, DD Sjoberg, BH Bochner, G Dalbagni, and others (2023). “Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma.” Journal of Clinical Oncology, 41 (8), 1618-1625

  14. MA Preston, JL Batista, KM Wilson, SV Carlsson, T Gerke, DD Sjoberg, and others (2016). “Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer.” Journal of Clinical Oncology, 34 (23), 2705

  15. S Punnen, DD Sjoberg, SM Zappala, D Parekh (2015). “A multi-institutional prospective trial in the United States to confirm the 4Kscore identification of men with high-grade prostate cancer.” JOURNAL OF CLINICAL ONCOLOGY, 33 (7)

  16. BH Bochner, DD Sjoberg, VP Laudone (2014). “A randomized trial of robot-assisted laparoscopic radical cystectomy.” New England journal of medicine, 371 (4), 389-390

  17. W Breitbart, S Poppito, B Rosenfeld, AJ Vickers, Y Li, J Abbey, M Olden, DD Sjoberg, and others (2012). “Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer.” Journal of clinical oncology, 30 (12), 1304

  18. V McPherson, SM Nair, AL Tin, M Dewar, K Siddiqui, DD Sjoberg, and others (2024). “Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsy-proven radio-recurrent localized prostate cancer.” Canadian Urological Association Journal, 18 (2)

  19. F Pellegrino, DD Sjoberg, AL Tin, NE Benfante, A Briganti, F Montorsi, and others (2023). “Relationship between age, comorbidity, and the prevalence of erectile dysfunction.” European urology focus, 9 (1), 162-167

  20. CA Bravi, P Dell’Oglio, E Mazzone, MC Moschovas, U Falagario, P Piazza, DD Sjoberg, and others (2023). “The surgical learning curve for biochemical recurrence after robot-assisted radical prostatectomy.” European Urology Oncology, 6 (4), 414-421

  21. H Truong, K Breen, S Nandakumar, DD Sjoberg, Y Kemel, N Mehta, and others (2023). “Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.” European Urology, 83 (1), 29-38

  22. MB Clements, BB Beech, TM Atkinson, GM Dalbagni, Y Li, AJ Vickers, DD Sjoberg, and others (2023). “Health-related quality of life after robotic-assisted vs open radical cystectomy: analysis of a randomized trial.” The Journal of urology, 209 (5), 901-910

  23. W Yip, DD Sjoberg, LM Nogueira, AT Tracey, RG Alvim, PA Reisz, and others (2023). “Final results of a phase I trial of WST-11 (TOOKAD Soluble) vascular-targeted photodynamic therapy for upper tract urothelial carcinoma.” The Journal of Urology, 209 (5), 863-871

  24. GT Chesnut, AL Tin, KA Fleshner, NE Benfante, AJ Vickers, JA Eastham, DD Sjoberg, and others (2023). “Estimating patient health in prostate cancer treatment counseling.” Prostate cancer and prostatic diseases, 26 (2), 271-275

  25. M Perera, G Jibara, AL Tin, S Haywood, DD Sjoberg, NE Benfante, and others (2023). “Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance.” European Urology Focus, 9 (4), 662-668

  26. BB Beech, AD Doudt, DD Sjoberg, MB Clements, AL Tin, TM Atkinson, and others (2023). “Association of smoking history on health-related quality of life in patients undergoing radical cystecomy.” Urologic Oncology: Seminars and Original Investigations,

  27. JA Lavery, S Brown, MA Curry, A Martin, DD Sjoberg, K Whiting (2023). “A data processing pipeline for the AACR project GENIE biopharma collaborative data with the {genieBPC} R package.” Bioinformatics, 39 (1), btac796

  28. F Pellegrino, DD Sjoberg, AL Tin, NE Benfante, A Briganti, F Montorsi, and others (2023). “Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy.” World Journal of Urology, 1-7

  29. A Mamtani, DD Sjoberg, A Vincent, B Ehdaie, D Malhotra, A Vickers, and others (2023). “Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?.” Breast Cancer Research and Treatment, 199 (1), 119-126

  30. F Pellegrino, AL Tin, DD Sjoberg, NE Benfante, RC Weber, SP Porwal, and others (2023). “The effect of the da Vinci® Vessel Sealer on robot-assisted laparoscopic prostatectomy complications.” Journal of Robotic Surgery, 1-6

  31. M Perera, S Lebdai, AL Tin, DD Sjoberg, N Benfante, BB Beech, RG Alvim, and others (2023). “Clinical-Prostate cancer Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence.” UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 41 (2)

  32. H Herr, EA Vertosick, G Dalbagni, EK Cha, R Smith, N Benfante, DD Sjoberg, and others (2023). “Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 Intravesical Instillations) of BCG Therapy for High-risk Non-muscle-invasive Bladder Cancer.” JOURNAL OF UROLOGY, 209 (2), 443-443

  33. M Perera, S Lebdai, AL Tin, DD Sjoberg, N Benfante, BB Beech, RG Alvim, and others (2023). “Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence.” Urologic Oncology: Seminars and Original Investigations, 41 (2), 105. e19-105 …

  34. B Ehdaie, CM Tempany, F Holland, DD Sjoberg, AS Kibel, QD Trinh, and others (2022). “MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.” The Lancet Oncology, 23 (7), 910-918

  35. N Almassi, EA Vertosick, DD Sjoberg, NC Wong, C Huang, EJ Pietzak, and others (2022). “Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.” BJU international, 129 (4), 463-469

  36. GA Jibara, M Perera, EA Vertosick, DD Sjoberg, A Vickers, PT Scardino, and others (2022). “Association of family history of cancer with clinical and pathological outcomes for prostate cancer patients on active surveillance.” The Journal of Urology, 208 (2), 325-332

  37. KM Kan, AL Tin, GL Stearns, JA Eastham, DD Sjoberg, JS Sandhu (2022). “De Novo Urinary Storage Symptoms Are Common after Radical Prostatectomy: Incidence, Natural History and Predictors.” The Journal of urology, 207 (3), 601-608

  38. C Huang, M Assel, BB Beech, NE Benfante, DD Sjoberg, A Touijer, and others (2022). “Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy.” BJU international, 130 (6), 809-814

  39. M Perera, A Vilaseca, AL Tin, DP Nguyen, RB Corradi, AS Touijer, DD Sjoberg, and others (2022). “Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach.” World Journal of Urology, 40 (7), 1637-1644

  40. S Dason, EA Vertosick, K Udo, DD Sjoberg, AJ Vickers, H Al‐Ahmadie, and others (2022). “Clinical utility of subclassifying positive surgical margins at radical prostatectomy.” BJU international, 129 (2), 194-200

  41. A Larcher, F Belladelli, U Capitanio, F Montorsi (2022). “Long-distance Robot-assisted Teleoperation: Every Millisecond Counts.” European urology, S, S0302-2838 (22) 02709-9

  42. AJ Vickers, DD Sjoberg (2022). “Methods Modernizing Statistical Reporting in Medical Journals: Challenges and Future Directions..” European Urology, S, S0302-2838 (22) 02643

  43. D Bock, M Nyberg, A Lantz, SV Carlsson, DD Sjoberg, S Carlsson, and others (2022). “Learning curve for robot-assisted laparoscopic radical prostatectomy in a large prospective multicentre study.” Scandinavian journal of urology, 56 (3), 182-190

  44. O Ettala, I Jambor, IM Perez, M Seppänen, A Kaipia, H Seikkula, DD Sjoberg, and others (2022). “Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled ….” BMJ open, 12 (4), e053118

  45. Y Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja (2022). “Systems for providing a probability of prostate cancer risk and/or prostate gland volume, and related methods.” US Patent App., 17/734,211

  46. C Huang, M Assel, BB Beech, NE Benfante, DD Sjoberg, A Touijer, and others (2022). “Ureteroenteric Stricture Outcomes: Secondary analysis of an RCT comparing open vs robotic cystectomy.” BJU international, 130 (6), 809

  47. AW Silagy, AL Tin, P Rappold, EA Vertosick, R Mano, K Attalla, A Yoo, DD Sjoberg, and others (2022). “Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma.” Clinical Genitourinary Cancer, 20 (5), e432-e439

  48. CA Bravi, P Dell’Oglio, E Mazzone, M C Moschovas, U Falagario, DD Sjoberg, and others (2022). “The surgical learning curve for cancer control after robot-assisted radical prostatectomy.” ,

  49. GT Chesnut, AL Tin, KA Fleshner, NE Benfante, AJ Vickers, JA Eastham, DD Sjoberg, and others (2022). “Correction: Estimating patient health in prostate cancer treatment counseling.” Prostate cancer and prostatic diseases, 25 (3), 598

  50. M Perera, A Vilaseca, A Tin, D Nguyen, R Carradi, A Touijer, N Benfante, DD Sjoberg, and others (2022). “Impact of the Minimally invasive approach on morbidity of salvage radical prosatectomy.” JOURNAL OF UROLOGY, 207 (5), E983-E983

  51. KA Touijer, DD Sjoberg, N Benfante, VP Laudone, B Ehdaie, JA Eastham, and others (2021). “Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial.” European urology oncology, 4 (4), 532-539

  52. M Nyberg, DD Sjoberg, SV Carlsson, U Wilderäng, S Carlsson, J Stranne, and others (2021). “Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial.” Bju International, 127 (3), 361-368

  53. CR Tracy, KJ Flynn, DD Sjoberg, PT Gellhaus, CM Metz, B Ehdaie (2021). “Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy cores.” Urologic Oncology: Seminars and Original Investigations, 39 (3), 193. e1-193. e6

  54. CA Bravi, G Rosiello, G Fallara, E Vertosick, A Tin, DD Sjoberg, M Bianchi, and others (2021). “Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution.” Minerva urology and nephrology, 73 (4), 481

  55. T Stonier, AL Tin, DD Sjoberg, G Jibara, AJ Vickers, S Fine, J Eastham (2021). “Selecting patients with favorable risk, grade group 2 prostate cancer for active surveillance—does magnetic resonance imaging have a role?.” The Journal of urology, 205 (4), 1063-1068

  56. GT Chesnut, AL Tin, DD Sjoberg, B Jang, N Benfante, S Sarraf, H Herr, and others (2021). “Electronic rapid fitness assessment identifies factors associated with adverse early postoperative outcomes following radical cystectomy.” The Journal of urology, 205 (2), 400-406

  57. H Herr, EA Vertosick, G Dalbagni, EK Cha, R Smith, N Benfante, DD Sjoberg, and others (2021). “Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non–muscle-invasive Bladder Cancer.” Urology, 157, 197-200

  58. B Ehdaie, G Jibara, DD Sjoberg, V Laudone, J Eastham, K Touijer, and others (2021). “The duration of antibiotics prophylaxis at the time of catheter removal after radical prostatectomy: clinically integrated, cluster, randomized trial.” The Journal of Urology, 206 (3), 662-668

  59. RG Alvim, AL Tin, L Nogueira, NC Wong, RC Fonseca, DD Sjoberg, and others (2021). “Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted Management.” Urology, 157, 174-180

  60. GL Stearns, AL Tin, NE Benfante, DD Sjoberg, JS Sandhu (2021). “Outcomes of ureteroneocystostomy in patients with cancer.” Urology, 158, 131-134

  61. G Jibara, DD Sjoberg, GL Stearns, Y Stabholz, A Fathollahi, LS Leddy, and others (2021). “Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.” Urology, 156, 225-230

  62. GT Chesnut, AL Tin, A Sivaraman, T Takeda, T Lee, J Fainberg, DD Sjoberg, and others (2021). “Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.” Urologic Oncology: Seminars and Original Investigations, 39 (8), 495. e17-495 …

  63. PE Lonergan, EA Vertosick, M Assel, DD Sjoberg, A Haese, M Graefen, and others (2021). “Prospective validation of microseminoprotein‐β added to the 4Kscore in predicting high‐grade prostate cancer in an international multicentre cohort.” BJU international, 128 (2), 218-224

  64. CA BRAVI, G ROSIELLO, G FALLARA, E VERTOSICK, A TIN, DD Sjoberg, and others (2021). “Minerva Urology and Nephrology 2021 August; 73 (4): 481-8.” Minerva, 73

  65. GT Chesnut, EA Vertosick, N Benfante, DD Sjoberg, J Fainberg, T Lee, and others (2020). “Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance.” European urology, 77 (4), 501-507

  66. S Carlsson, N Benfante, R Alvim, DD Sjoberg, A Vickers, VE Reuter, and others (2020). “Long-term outcomes of active surveillance for prostate cancer: the Memorial Sloan Kettering Cancer Center experience.” The Journal of urology, 203 (6), 1122-1127

  67. S Carlsson, N Benfante, R Alvim, DD Sjoberg, A Vickers, VE Reuter, and others (2020). “Risk of metastasis in men with grade group 2 prostate cancer managed with active surveillance at a tertiary cancer center.” The Journal of urology, 203 (6), 1117-1121

  68. AJ Vickers, MJ Assel, DD Sjoberg, R Qin, Z Zhao, T Koyama, A Botchway, and others (2020). “Guidelines for reporting of figures and tables for clinical research in urology.” The Journal of Urology, 204 (1), 121-133

  69. KA Amin, EA Vertosick, G Stearns, A Fathollahi, DD Sjoberg, MS Donat, and others (2020). “Predictors of benign ureteroenteric anastomotic strictures after radical cystectomy and urinary diversion.” Urology, 144, 225-229

  70. EA Vertosick, C Häggström, DD Sjoberg, G Hallmans, R Johansson, and others (2020). “Prespecified 4-Kallikrein marker model at age 50 or 60 for early detection of lethal prostate cancer in a large population based cohort of asymptomatic men followed for 20 years.” The Journal of urology, 204 (2), 281-288

  71. N Almassi, EK Cha, EA Vertosick, C Huang, N Wong, S Dason, DD Sjoberg, and others (2020). “Trends in management and outcomes among patients with urothelial carcinoma undergoing radical cystectomy from 1995 to 2015: the Memorial Sloan Kettering experience.” The Journal of urology, 204 (4), 677-684

  72. R Mano, EA Vertosick, J Sarcona, DD Sjoberg, NE Benfante, TF Donahue, and others (2020). “Primary urethral cancer: treatment patterns and associated outcomes.” BJU international, 126 (3), 359-366

  73. A Vilaseca, G Guglielmetti, EA Vertosick, DD Sjoberg, A Grasso, and others (2020). “Value of partial nephrectomy for renal cortical tumors of cT2 or greater stage: a risk-benefit analysis of renal function preservation versus increased postoperative morbidity.” European urology oncology, 3 (3), 365-371

  74. A Haese, AL Tin, SV Carlsson, DD Sjoberg, D Pehrke, T Steuber, and others (2020). “A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy.” British Journal of Cancer, 123 (4), 604-609

  75. CA Bravi, A Tin, E Vertosick, E Mazzone, M Bandini, P Dell’Oglio, DD Sjoberg, and others (2020). “Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy.” Urologic Oncology: Seminars and Original Investigations, 38 (4), 204-209

  76. GT Chesnut, P Zareba, DD Sjoberg, M Mamoor, S Carlsson, T Lee, and others (2020). “Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsy.” Canadian Urological Association Journal, 14 (5), E202

  77. JC Hu, B Ehdaie, J Sandhu, DD Sjoberg, SV Carlsson, M Tzeng, and others (2020). “Asian-American race and urinary continence after radical prostatectomy.” European Urology Open Science, 22, 51

  78. GT Chesnut, N Benfante, D Barham, LW Dean, A Tin, DD Sjoberg, and others (2020). “Routine postoperative hemoglobin assessment poorly predicts transfusion requirement among patients undergoing minimally invasive radical prostatectomy.” Urology practice, 7 (4), 299-304

  79. S Erestam, D Bock, A Erichsen Andersson, A Bjartell, S Carlsson, DD Sjoberg, and others (2020). “Associations between intraoperative factors and surgeons’ self-assessed operative satisfaction.” Surgical endoscopy, 34, 61-68

  80. S Dason, EK Cha, C Falavolti, EA Vertosick, LW Dean, VA McPherson, DD Sjoberg, and others (2020). “Late recurrences following radical cystectomy have distinct prognostic and management considerations.” The Journal of urology, 204 (3), 460-465

  81. W Li, M Bicak, DD Sjoberg, E Vertosick, A Dahlin, O Melander, D Ulmert, and others (2020). “Genome‐wide association study identifies novel single nucleotide polymorphisms having age‐specific effect on prostate‐specific antigen levels.” The Prostate, 80 (16), 1405-1412

  82. CA Bravi, A Tin, E Vertosick, E Mazzone, M Bandini, P Dell’Oglio, DD Sjoberg, and others (2020). “Relative contribution of androgen deprivation therapy in combination with adjuvant radiotherapy for node-positive prostate cancer..” Urologic oncology, 38 (4), 204

  83. T Takeda, AL Tin, RB Corradi, R Alvim, T Hashimoto, Y Ito, DP Nguyen, DD Sjoberg, and others (2020). “Extensive disease among potential candidates for hemi‐ablative focal therapy for prostate cancer.” International Journal of Urology, 27 (2), 179-185

  84. KA Touijer, DD Sjoberg, N Benfante, NP Brau, IR Belenchón, CM Barrull, and others (2020). “Comparison of erectile function recovery between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized ….” European Urology Open Science, 19, e2124

  85. M Assel, DD Sjoberg, A Elders, X Wang, D Huo, A Botchway, K Delfino, and others (2019). “Guidelines for reporting of statistics for clinical research in urology.” BJU international, 123 (3), 401-410

  86. CA Bravi, E Vertosick, N Benfante, A Tin, DD Sjoberg, AA Hakimi, K Touijer, and others (2019). “Impact of acute kidney injury and its duration on long-term renal function after partial nephrectomy.” European urology, 76 (3), 398-403

  87. MA Preston, T Gerke, SV Carlsson, L Signorello, DD Sjoberg, SC Markt, and others (2019). “Baseline prostate-specific antigen level in midlife and aggressive prostate cancer in black men.” European urology, 75 (3), 399-407

  88. LW Dean, M Assel, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, YB Chen, and others (2019). “Clinical usefulness of total length of Gleason pattern 4 on biopsy in men with grade group 2 prostate cancer.” The Journal of urology, 201 (1), 77-83

  89. X Wu, H Scott, SV Carlsson, DD Sjoberg, L Cerundolo, H Lilja, R Prevo, and others (2019). “Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.” The Prostate, 79 (10), 1079-1089

  90. Y Ito, K Udo, EA Vertosick, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, and others (2019). “Clinical usefulness of prostate and tumor volume related parameters following radical prostatectomy for localized prostate cancer.” The Journal of urology, 201 (3), 535-540

  91. P Capogrosso, EA Vertosick, NE Benfante, DD Sjoberg, AJ Vickers, and others (2019). “Can we improve the preoperative prediction of prostate cancer recurrence with multiparametric MRI?.” Clinical genitourinary cancer, 17 (4), e745-e750

  92. Y Ito, EA Vertosick, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, YB Chen, and others (2019). “In organ-confined prostate cancer, tumor quantitation not found to aid in prediction of biochemical recurrence.” The American journal of surgical pathology, 43 (8), 1061-1065

  93. NC Wong, RG Alvim, DD Sjoberg, R Shingarev, NE Power, M Spaliviero, and others (2019). “Phase III trial of intravenous mannitol versus placebo during nephron-sparing surgery: post hoc analysis of 3-yr outcomes.” European urology focus, 5 (6), 977-979

  94. M Assel, DD Sjoberg, JWF Catto, AJ Vickers (2019). “Innovations in statistical review at European Urology.” European urology, 75 (1), 1

  95. GT Chesnut, P Zareba, DD Sjoberg, M Mamoor, S Carlsson, T Lee (2019). “Patient experience of MRI-targeted prostate biopsy Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsy.” Can Urol Assoc J, 29

  96. S Fine, Y Ito, E Vertosick, DD Sjoberg, A Vickers, H Al-Ahmadie, YB Chen, and others (2019). “In Organ-Confined Prostate Cancer at Radical Prostatectomy, neither Total Tumor Volume nor Maximum Tumor Diameter of the Index Lesion Aids in Prediction of Biochemical Recurrence.” LABORATORY INVESTIGATION, 99

  97. BH Bochner, G Dalbagni, KH Marzouk, DD Sjoberg, J Lee, SM Donat, and others (2018). “Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: oncologic outcomes.” European urology, 74 (4), 465-471

  98. KA Touijer, RJ Karnes, N Passoni, DD Sjoberg, M Assel, N Fossati, and others (2018). “Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies.” European urology, 73 (6), 890-896

  99. M Nyberg, J Hugosson, P Wiklund, DD Sjoberg, U Wilderäng, SV Carlsson, and others (2018). “Functional and oncologic outcomes between open and robotic radical prostatectomy at 24-month follow-up in the Swedish LAPPRO trial.” European urology oncology, 1 (5), 353-360

  100. M Spaliviero, NE Power, KS Murray, DD Sjoberg, NE Benfante, and others (2018). “Intravenous mannitol versus placebo during partial nephrectomy in patients with normal kidney function: a double-blind, clinically-integrated, randomized trial.” European urology, 73 (1), 53-59

  101. W Li, M Middha, M Bicak, DD Sjoberg, E Vertosick, A Dahlin, and others (2018). “Genome-wide scan identifies role for AOX1 in prostate cancer survival.” European urology, 74 (6), 710-719

  102. E Kovac, EA Vertosick, DD Sjoberg, AJ Vickers, AJ Stephenson (2018). “Effects of pathological upstaging or upgrading on metastasis and cancer‐specific mortality in men with clinical low‐risk prostate cancer.” BJU international, 122 (6), 1003-1009

  103. EK Cha, JP Sfakianos, R Sukhu, AM Yee, DD Sjoberg, BH Bochner (2018). “Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.” BJU international, 122 (4), 627-632

  104. AD Mally, AL Tin, JK Lee, P Satasivam, EK Cha, SM Donat, HW Herr, DD Sjoberg, and others (2018). “Clinical outcomes of patients with T1 nested variant of urothelial carcinoma compared to pure urothelial carcinoma of the bladder.” Clinical genitourinary cancer, 16 (1), e23-e27

  105. T Takeda, AL Tin, RB Corradi, M Mamoor, NE Benfante, DD Sjoberg, and others (2018). “Topography of prostate cancer recurrence after radiation therapy: a detailed mapping study of salvage radical prostatectomy specimens.” European urology, 73 (4), 488-490

  106. RG Alvim, F Audenet, EA Vertosick, DD Sjoberg, KA Touijer (2018). “Performance prediction for surgical outcomes in partial nephrectomy using nephrometry scores: a comparison of Arterial Based Complexity (ABC), RENAL, and PADUA systems.” European urology oncology, 1 (5), 428-434

  107. M Rieken, LA Kluth, H Fajkovic, U Capitanio, A Briganti, LM Krabbe, DD Sjoberg, and others (2018). “Predictors of cancer-specific survival after disease recurrence in patients with renal cell carcinoma: the effect of time to recurrence.” Clinical genitourinary cancer, 16 (4), e903-e908

  108. K Marzouk, A Tin, N Liu, DD Sjoberg, AA Hakimi, P Russo, J Coleman (2018). “The natural history of large renal masses followed on observation.” Urologic Oncology: Seminars and Original Investigations, 36 (8), 362. e17-362 …

  109. CM Dowling, M Assel, JE Musser, JJ Meeks, DD Sjoberg, G Bosl, and others (2018). “Clinical outcome of retroperitoneal lymph node dissection after chemotherapy in patients with pure embryonal carcinoma in the orchiectomy specimen.” Urology, 114, 133-138

  110. AJ Vickers, EA Vertosick, DD Sjoberg (2018). “Value of a statistical model based on four kallikrein markers in blood, commercially available as 4Kscore, in all reasonable prostate biopsy subgroups.” European urology, 74 (4), 535

  111. P Capogrosso, A Larcher, DD Sjoberg, EA Vertosick, F Cianflone, and others (2018). “Risk based surveillance after surgical treatment of renal cell carcinoma.” Journal of Urology, 200 (1), 61-67

  112. L Marconi, R de Bruijn, E van Werkhoven, C Beisland, K Fife, DD Sjoberg, and others (2018). “External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.” World journal of urology, 36, 1973-1980

  113. A Vickers, EA Vertosick, DD Sjoberg, F Hamdy, D Neal, A Bjartell, and others (2018). “Value of intact prostate specific antigen and human kallikrein 2 in the 4 kallikrein predictive model: an individual patient data meta-analysis.” The Journal of urology, 199 (6), 1470-1474

  114. JK Lee, DD Sjoberg, MI Miller, AJ Vickers, JP Mulhall, B Ehdaie (2018). “Improved recovery of erectile function in younger men after radical prostatectomy: Does it justify immediate surgery in low-risk patients?.” European urology, 73 (1), 33-37

  115. KS Murray, EA Vertosick, M Spaliviero, JW Mashni Jr, DD Sjoberg, and others (2018). “Importance of wide re‐resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution.” Journal of surgical oncology, 117 (7), 1464-1468

  116. A Bagrodia, R Sukhu, AG Winer, E Levy, M Vacchio, B Lee, EJ Pietzak, DD Sjoberg, and others (2018). “Incidence and effect of thromboembolic events in radical cystectomy patients undergoing preoperative chemotherapy for muscle-invasive bladder cancer.” Clinical genitourinary cancer, 16 (1), e113-e120

  117. K Lapen, L Benusis, S Pearson, B Search, M Coleton, QS Li, DD Sjoberg, and others (2018). “A feasibility study of restorative yoga versus vigorous yoga intervention for sedentary breast and ovarian cancer survivors.” International journal of yoga therapy, 28 (1), 79-85

  118. F Audenet, EA Vertosick, SW Fine, DD Sjoberg, AJ Vickers, VE Reuter, and others (2018). “Biopsy core features are poor predictors of adverse pathology in men with grade group 1 prostate cancer.” The Journal of urology, 199 (4), 961-968

  119. M Ghanaat, AG Winer, DD Sjoberg, BY Poon, M Kashan, AL Tin, and others (2018). “Comparison of postradical cystectomy ileus rates using GIA-80 versus GIA-60 intestinal stapler device.” Urology, 122, 121-126

  120. EJ Pietzak, M Assel, MF Becerra, D Tennenbaum, DR Feldman, DD Sjoberg, and others (2018). “Histologic and oncologic outcomes following liver mass resection with retroperitoneal lymph node dissection in patients with nonseminomatous germ cell tumor.” Urology, 118, 114-118

  121. DP Nguyen, EA Vertosick, V Sharma, RB Corradi, A Vilaseca, T Takeda, DD Sjoberg, and others (2018). “Does subclassification of pathologically organ confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy?.” The Journal of urology, 199 (6), 1502-1509

  122. AE Thong, BY Poon, JK Lee, E Vertosick, DD Sjoberg, AJ Vickers, and others (2018). “Concordance between patient-reported and physician-reported sexual function after radical prostatectomy.” Urologic Oncology: Seminars and Original Investigations, 36 (2), 80. e1-80. e6

  123. Y Ito, K Udo, EA Vertosick, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, and others (2018). “Clinical utility of prostate and tumor volume-related parameters following radical prostatectomy for localized prostate cancer.” The Journal of Urology,

  124. E Kovac, EA Vertosick, DD Sjoberg, AJ Vickers, AJ Stephenson (2018). “Re: Effects of Pathological Upstaging or Upgrading on Metastasis and Cancer-Specific Mortality in Men with Clinical Low-Risk Prostate Cancer Editorial Comment.” JOURNAL OF UROLOGY, 200 (5), 945-946

  125. NT John, A Tin, RG Dinatale, NE Benfante, DD Sjoberg, AA Hakimi, and others (2018). “Genomic Predictors of Response to Neoadjuvant Cisplatin-based Chemotherapy in Upper Tract Urothelial Carcinoma (UTUC).” JOURNAL OF UROLOGY, 199 (4), E216-E216

  126. NT John, A Tin, DD Sjoberg, NE Benfante, AA Hakimi, P Russo, and others (2018). “Can Imaging Response following Neoadjuvant Chemotherapy in Upper Tract Urothelial Cancer be a Surrogate for Pathologic Response?.” JOURNAL OF UROLOGY, 199 (4), E214-E215

  127. SW Fine, H Al-Ahmadie, E Vertosick, DD Sjoberg, A Vickers, YB Chen, and others (2018). “Impact of Zone of Origin in Anterior-Dominant Prostatic Tumors: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Annotated Series.” LABORATORY INVESTIGATION, 98, 340-340

  128. K Mooney, DL Berry, M Whisenant, DD Sjoberg (2017). “Improving cancer care through the patient experience: how to use patient-reported outcomes in clinical practice.” American Society of Clinical Oncology Educational Book, 37, 695-704

  129. M Assel, DD Sjoberg, AJ Vickers (2017). “The Brier score does not evaluate the clinical utility of diagnostic tests or prediction models.” Diagnostic and prognostic research, 1 (1), 1-7

  130. DW Lin, LF Newcomb, MD Brown, DD Sjoberg, Y Dong, JD Brooks, and others (2017). “Evaluating the four kallikrein panel of the 4Kscore for prediction of high-grade prostate cancer in men in the Canary Prostate Active Surveillance Study.” European urology, 72 (3), 448-454

  131. MJ O’Shaughnessy, SM McBride, HA Vargas, KA Touijer, MJ Morris, DD Sjoberg, and others (2017). “A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer.” Urology, 102, 164-172

  132. R Chen, DD Sjoberg, Y Huang, L Xie, L Zhou, D He, AJ Vickers, Y Sun (2017). “Prostate specific antigen and prostate cancer in Chinese men undergoing initial prostate biopsies compared with Western cohorts.” The Journal of urology, 197 (1), 90-96

  133. SM Zappala, Y Dong, V Linder, M Reeve, DD Sjoberg, V Mathur, and others (2017). “The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE information.” International journal of clinical practice, 71 (6), e12943

  134. EH Kim, GL Andriole, ED Crawford, DD Sjoberg, M Assel, AJ Vickers, and others (2017). “Detection of high grade prostate cancer among PLCO participants using a prespecified 4-kallikrein marker panel.” The Journal of urology, 197 (4), 1041-1047

  135. BJ Manley, DM Tennenbaum, EA Vertosick, JJ Hsieh, DD Sjoberg, and others (2017). “The difficulty in selecting patients for cytoreductive nephrectomy: an evaluation of previously described predictive models.” Urologic Oncology: Seminars and Original Investigations, 35 (1), 35. e1-35. e5

  136. A Vickers, EA Vertosick, DD Sjoberg, MJ Roobol, F Hamdy, D Neal, and others (2017). “Properties of the 4-kallikrein panel outside the diagnostic gray zone: meta-analysis of patients with positive digital rectal examination or prostate specific antigen 10 ng/ml ….” The Journal of urology, 197 (3), 607-613

  137. A Vilaseca, DP Nguyen, EA Vertosick, RB Corradi, M Musquera, M Pérez, DD Sjoberg, and others (2017). “Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically.” World journal of urology, 35, 51-56

  138. AG Winer, EA Vertosick, M Ghanaat, RB Corradi, S Carlsson, DD Sjoberg, and others (2017). “Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.” Urologic Oncology: Seminars and Original Investigations, 35 (4), 151. e9-151. e15

  139. G Dalbagni, N Benfante, DD Sjoberg, BH Bochner, S Machele Donat, and others (2017). “Single arm phase I/II study of everolimus and intravesical gemcitabine in patients with primary or secondary carcinoma in situ of the bladder who failed bacillus Calmette ….” Bladder Cancer, 3 (2), 113-119

  140. RB Corradi, EA Vertosick, DP Nguyen, A Vilaseca, DD Sjoberg, and others (2017). “Nephrometry scores and perioperative outcomes following robotic partial nephrectomy.” International braz j urol, 43, 1075-1083

  141. S Punnen, B Nahar, NS Prakash, DD Sjoberg, SM Zappala, DJ Parekh (2017). “The 4Kscore predicts the grade and stage of prostate cancer in the radical prostatectomy specimen: results from a multi-institutional prospective trial.” European urology focus, 3 (1), 94-99

  142. A Polland, EA Vertosick, DD Sjoberg, GL Stearns, LS Leddy, and others (2017). “Preoperative symptoms predict continence after post-radiation transurethral resection of prostate..” The Canadian Journal of Urology, 24 (4), 8903-8909

  143. DP Nguyen, M Kent, A Vilaseca, RB Corradi, N Fossati, DD Sjoberg, and others (2017). “Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy.” Prostate Cancer and Prostatic Diseases, 20 (1), 105-109

  144. Y Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja (2017). “Compositions and methods for active surveillance of prostate cancer.” US Patent App., 15/143,345

  145. LH Rosenberger, R Weber, DD Sjoberg, AJ Vickers, DA Mangino, and others (2017). “Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on ….” Breast cancer research and treatment, 162, 275-282

  146. JI Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L Egevad, and others (2016). “A contemporary prostate cancer grading system: a validated alternative to the Gleason score.” European urology, 69 (3), 428-435

  147. K Braun, DD Sjoberg, AJ Vickers, H Lilja, AS Bjartell (2016). “A four-kallikrein panel predicts high-grade cancer on biopsy: independent validation in a community cohort.” European urology, 69 (3), 505-511

  148. M Spaliviero, BY Poon, CA Karlo, GB Guglielmetti, PL Di Paolo, DD Sjoberg, and others (2016). “An arterial based complexity (ABC) scoring system to assess the morbidity profile of partial nephrectomy.” European urology, 69 (1), 72-79

  149. P Recabal, M Assel, DD Sjoberg, D Lee, VP Laudone, K Touijer, and others (2016). “The efficacy of multiparametric magnetic resonance imaging and magnetic resonance imaging targeted biopsy in risk classification for patients with prostate cancer on active ….” The Journal of urology, 196 (2), 374-381

  150. DP Nguyen, EA Vertosick, RB Corradi, A Vilaseca, NE Benfante, DD Sjoberg, and others (2016). “Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.” Urologic Oncology: Seminars and original investigations, 34 (6), 259. e1-259. e8

  151. C Anderson, R Weber, D Patel, W Lowrance, A Mellis, M Cookson, DD Sjoberg, and others (2016). “A 10-item checklist improves reporting of critical procedural elements during transurethral resection of bladder tumor.” The Journal of urology, 196 (4), 1014-1020

  152. M Imnadze, DD Sjoberg, AJ Vickers (2016). “Adverse pathologic features at radical prostatectomy: effect of preoperative risk on oncologic outcomes.” European urology, 69 (1), 143-148

  153. DJ Lee, P Recabal, DD Sjoberg, A Thong, JK Lee, JA Eastham, and others (2016). “Comparative effectiveness of targeted prostate biopsy using magnetic resonance imaging ultrasound fusion software and visual targeting: a prospective study.” The Journal of Urology, 196 (3), 697-702

  154. CD Jakubowski, EA Vertosick, BR Untch, DD Sjoberg, E Wei, FL Palmer, and others (2016). “Complete metastasectomy for renal cell carcinoma: comparison of five solid organ sites.” Journal of surgical oncology, 114 (3), 375-379

  155. A Sankin, AL Tin, R Mano, M Chevinsky, C Jakubowski, JP Sfakianos, DD Sjoberg, and others (2016). “Impact of ureteroscopy before nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes.” Urology, 94, 148-153

  156. LV Selby, M Sovel, DD Sjoberg, M McSweeney, D Douglas, DR Jones, and others (2016). “Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism.” Journal of the American College of Surgeons, 222 (2), 129-137

  157. R Mano, EA Vertosick, AA Hakimi, IA Sternberg, DD Sjoberg, M Bernstein, and others (2016). “The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4 cm.” Urologic Oncology: Seminars and Original Investigations, 34 (5), 239. e1-239. e8

  158. N Fossati, NM Passoni, M Moschini, G Gandaglia, A Larcher, M Freschi, DD Sjoberg, and others (2016). “Impact of stage migration and practice changes on high‐risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.” BJU international, 117 (5), 740-747

  159. WM Bazzi, AL Tin, DD Sjoberg, M Bernstein, P Russo (2016). “The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma.” The Canadian journal of urology, 23 (1), 8151

  160. A Rönnblom, T Holmström, H Tanghöj, U Karlbom, M Thörn, D Sjöberg (2016). “Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005–2009.” Scandinavian Journal of Gastroenterology, 51 (11), 1339-1344

  161. NW Liu, JD Wren, E Vertosick, JK Lee, NE Power, NE Benfante, SY Kimm, DD Sjoberg, and others (2016). “The prognostic impact of a positive vascular margin on pT3 clear cell renal cell carcinoma.” The Journal of urology, 195 (2), 264-269

  162. DP Nguyen, A Vilaseca, EA Vertosick, RB Corradi, KA Touijer, DD Sjoberg, and others (2016). “Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.” World journal of urology, 34, 539-544

  163. A Ronnblom, T Holmstrom, H Tanghoj, U Karlbom, M Thorn, DD Sjoberg (2016). “Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.” Scandinavian journal of gastroenterology, 51 (11), 1339-1344

  164. P Recabal, M Assel, JE Musser, RJ Caras, DD Sjoberg, JA Coleman, and others (2016). “Erectile function recovery after radical prostatectomy in men with high risk features.” The Journal of urology, 196 (2), 507-513

  165. DJ Lee, P Recabal, DD Sjoberg, A Thong, JK Lee, JA Eastham, and others (2016). “Comparative effectiveness of targeted prostate biopsy using MRI-US fusion software and visual targeting: a prospective study.” The Journal of urology, 196 (3), 697

  166. B Ehdaie, BY Poon, DD Sjoberg, P Recabal, V Laudone, K Touijer, and others (2016). “Variation in serum prostate‐specific antigen levels in men with prostate cancer managed with active surveillance.” BJU international, 118 (4), 535-540

  167. CB Anderson, AL Tin, DD Sjoberg, JP Mulhall, J Sandhu, K Touijer, and others (2016). “Association between number of prostate biopsies and patient‐reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.” BJU international, 117 (6B), E46-E51

  168. G Gugliemetti, R Sukhu, MAC Baenas, J Meeks, DD Sjoberg, JA Eastham, and others (2016). “Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.” Actas Urológicas Españolas (English Edition), 40 (7), 434-439

  169. P Recabal, M Assel, DD Sjoberg, D Lee, VP Laudone, K Touijer, and others (2016). “The efficacy of multiparametric magnetic resonance imaging and MRI-targeted biopsy in risk classification for patients with prostate cancer on active surveillance.” The Journal of urology, 196 (2), 374

  170. Y Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja (2016). “Compositions and methods for active surveillance of prostate cancer.” US Patent App., 15/143,329

  171. MA Feuerstein, JE Musser, M Kent, M Chevinsky, EK Cha, S Kimm, DD Sjoberg, and others (2016). “Low yield of surveillance imaging after surgery for T1 kidney cancer.” World journal of urology, 34, 949-953

  172. A Vilaseca Cabo, D Nguyen, A Tin, R Corradi, A Martin-Malburet, DD Sjoberg, and others (2016). “433 Long-term oncological outcomes of salvage radical prostatectomy for radio-recurrent/persistent prostate cancer after radiation therapy.” EUROPEAN UROLOGY-SUPPLEMENTS-, 15 (3), e433-e433

  173. G Gugliemetti, R Sukhu, MAC Baenas, J Meeks, DD Sjoberg, JA Eastham, and others (2016). “Número de ganglios linfáticos metastásicos como determinante de los resultados de la prostatectomía radical de rescate en el cáncer de próstata de recidivante tras radioterapia.” Actas Urológicas Españolas, 40 (7), 434-439

  174. D Lin, M Brown, L Newcomb, DD Sjoberg, J Brooks, P Carroll, A Dash, and others (2016). “PD08-02 evaluating the four kallikrein panel of the 4kscore for prediction of high-grade prostate cancer in men in the canary prostate active surveillance study (PASS).” The Journal of Urology, 195 (4S), e229-e229

  175. J Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L Egevad, and others (2016). “A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score (Retraction of Vol 69, Pg 428, 2016).” PATHOLOGY INTERNATIONAL, 66 (10), 600-+

  176. D Siemens, LH Klotz, A Heidenreich, S Chowdhury, A Villers, B Baron, DD Sjoberg, and others (2016). “Podium Session 1: Prostate Cancer June 26, 2016 1050-1150.” CUAJ, 10, 5-6Suppl1

  177. BH Bochner, G Dalbagni, DD Sjoberg, J Silberstein, GEK Paz, SM Donat, and others (2015). “Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial.” European urology, 67 (6), 1042-1050

  178. DJ Parekh, S Punnen, DD Sjoberg, SW Asroff, JL Bailen, JS Cochran, and others (2015). “A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.” European urology, 68 (3), 464-470

  179. RJ Bryant, DD Sjoberg, AJ Vickers, MC Robinson, R Kumar, L Marsden, and others (2015). “Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.” Journal of the National Cancer Institute, 107 (7), djv095

  180. P Stattin, AJ Vickers, DD Sjoberg, R Johansson, T Granfors, M Johansson, and others (2015). “Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case–control study.” European urology, 68 (2), 207-213

  181. AJ Vickers, DD Sjoberg (2015). “Guidelines for reporting of statistics in European Urology.” Eur Urol, 67 (2), 181-187

  182. LV Selby, EA Vertosick, DD Sjoberg, MA Schattner, YY Janjigian, and others (2015). “Morbidity after total gastrectomy: analysis of 238 patients.” Journal of the American College of Surgeons, 220 (5), 863-871. e2

  183. JK Lee, M Assel, AE Thong, DD Sjoberg, JP Mulhall, J Sandhu, and others (2015). “Unexpected long-term improvements in urinary and erectile function in a large cohort of men with self-reported outcomes following radical prostatectomy.” European urology, 68 (5), 899-905

  184. M Spaliviero, BY Poon, O Aras, PL Di Paolo, GB Guglielmetti, DD Sjoberg, and others (2015). “Interobserver variability of RENAL, PADUA, and centrality index nephrometry score systems.” World journal of urology, 33, 853-858

  185. KM Wesa, NH Segal, AM Cronin, DD Sjoberg, GN Jacobs, MI Coleton, and others (2015). “Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis.” Nutrition and cancer, 67 (3), 424-430

  186. M Chevinsky, M Imnadze, A Sankin, A Winer, R Mano, C Jakubowski, DD Sjoberg, and others (2015). “Pathological stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma.” The Journal of urology, 194 (2), 310-315

  187. WM Bazzi, DD Sjoberg, MA Feuerstein, A Maschino, S Verma, and others (2015). “Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.” The Journal of urology, 193 (6), 1911-1917

  188. R Mano, M Kent, Y Larish, AG Winer, MS Chevinsky, AA Hakimi, DD Sjoberg, and others (2015). “Partial and radical nephrectomy for unilateral synchronous multifocal renal cortical tumors.” Urology, 85 (6), 1404-1410

  189. JL Silberstein, SA Poon, DD Sjoberg, AC Maschino, AJ Vickers, A Bernie, and others (2015). “Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk ….” BJU international, 116 (1), 50-56

  190. R Mano, E Vertosick, AI Sankin, MS Chevinsky, Y Larish, CD Jakubowski, DD Sjoberg, and others (2015). “Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.” The Journal of urology, 193 (3), 776-782

  191. CB Anderson, IA Sternberg, G Karen-Paz, PH Kim, DD Sjoberg, HA Vargas, and others (2015). “Age is associated with upgrading at confirmatory biopsy among men with prostate cancer treated with active surveillance.” The Journal of Urology, 194 (6), 1607-1611

  192. TP Ghoneim, DD Sjoberg, W Lowrance, SF Shariat, C Savage, and others (2015). “Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics.” World journal of urology, 33, 2023-2029

  193. LV Selby, DD Sjoberg, D Cassella, M Sovel, MR Weiser, K Sepkowitz, and others (2015). “Comparing surgical infections in national surgical quality improvement project and an institutional database.” Journal of Surgical Research, 196 (2), 416-420

  194. WM Bazzi, DD Sjoberg, AAC Grasso, M Bernstein, R Parra, JA Coleman (2015). “Predicting length of stay after robotic partial nephrectomy.” International urology and nephrology, 47, 1321-1325

  195. T Gondo, BY Poon, K Matsumoto, M Bernstein, DD Sjoberg, JA Eastham (2015). “Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed G leason score 3+ 4 prostate cancer.” BJU international, 115 (1), 81-86

  196. N Fossati, A Larcher, GM Gadda, DD Sjoberg, FA Mistretta, P Dell’Oglio, and others (2015). “Minimally invasive partial nephrectomy versus laparoscopic cryoablation for patients newly diagnosed with a single small renal mass.” European Urology Focus, 1 (1), 66-72

  197. WM Bazzi, LY Chen, BH Cordon, J Mashni, DD Sjoberg, M Bernstein, and others (2015). “Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function.” International urology and nephrology, 47, 1499-1502

  198. N Fossati, DD Sjoberg, U Capitanio, G Gandaglia, A Larcher, A Nini, and others (2015). “Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.” BJU international, 116 (3), 366-372

  199. JE Musser, MJ Assel, JJ Meeks, DD Sjoberg, AJ Vickers, JA Coleman, and others (2015). “Ambulatory extended recovery: safely transitioning to overnight observation for minimally invasive prostatectomy.” Urology Practice, 2 (3), 121-125

  200. C Eriksson, S Almer, JA Bjork, M Eberhardson, A Eriksson, O Grip, DD Sjoberg, and others (2015). “Vedolizumab in inflammatory bowel disease, the first experience from the Swedish IBD Registry (SWIBREG).” Gastroenterology, 148 (4), S871-S871

  201. M Cesarini, G Collins, A Ronnblom, A Santos, DD Sjoberg, M Parkes, and others (2015). “Predicting the risk of acute severe colitis (ASC) at diagnosis of Ulcerative Colitis (UC): external validation.” Journal of Crohn’s and Colitis, 9 (suppl 1)

  202. AJ Vickers, DD Sjoberg (2015). “Decision analysis of dutasteride use for patients with negative prostate biopsy.” Urology, 85 (2), 337-342

  203. S Punnen, S Zappala, J Palou, DD Sjoberg, V Mathur, R Roberts, V Vincent, and others (2015). “433 Among men with low-grade prostate cancer on prostate biopsy, the 4Kscore predicts the presence of more aggressive prostate cancer.” European urology supplements: official journal of the European Association …,

  204. A Bondarik, D Sjöberg (2015). “Implementation of UC-EBG structure for 60 GHz gridded parasitic patch stacked microstrip antenna.” , 2015 9th European Conference on Antennas and Propagation (EuCAP), 1-5

  205. JL Silberstein, SA Poon, DD Sjoberg (2015). “Neoadjuvante Chemohormontherapie vor radikaler Prostatektomie?.” Urologie Scan, 2 (04), 251-251

  206. BH Bochner, G Dalbagni, DD Sjoberg (2015). “Offen chirurgische versus roboterassistierte laparoskopische radikale Zystektomie.” Urologie Scan, 2 (04), 247-247

  207. EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, DD Sjoberg, M Assel, and others (2014). “Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.” European urology, 66 (3), 489-499

  208. KA Touijer, CR Mazzola, DD Sjoberg, PT Scardino, JA Eastham (2014). “Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.” European urology, 65 (1), 20-25

  209. S Carlsson, M Assel, DD Sjoberg, D Ulmert, J Hugosson, H Lilja, A Vickers (2014). “Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.” Bmj, 348

  210. AJ Vickers, DD Sjoberg, D Ulmert, E Vertosick, MJ Roobol, I Thompson, and others (2014). “Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.” BMC medicine, 12, 1-7

  211. M Spaliviero, G Dalbagni, BH Bochner, BY Poon, H Huang, DD Sjoberg, and others (2014). “Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.” The Journal of urology, 192 (3), 702-707

  212. K Braun, Y Ahallal, DD Sjoberg, T Ghoneim, MD Esteban, J Mulhall, and others (2014). “Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer.” The Journal of urology, 191 (3), 744-749

  213. T Tarin, A Feifer, S Kimm, L Chen, DD Sjoberg, J Coleman, P Russo (2014). “Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.” The Journal of urology, 191 (5), 1225-1230

  214. T Tarin, A Feifer, S Kimm, L Chen, DD Sjoberg, J Coleman, P Russo (2014). “Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.” The Journal of urology, 191 (5), 1225-1230

  215. JE Musser, M Assel, JW Mashni, DD Sjoberg, P Russo (2014). “Adult prostate sarcoma: the Memorial Sloan Kettering experience.” Urology, 84 (3), 624-628

  216. M Matignon, R Ding, DM Dadhania, FB Mueller, C Hartono, DD Sjoberg, and others (2014). “Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction.” Journal of the American Society of Nephrology: JASN, 25 (7), 1586

  217. PH Kim, R Sukhu, BH Cordon, JP Sfakianos, DD Sjoberg, AA Hakimi, and others (2014). “Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.” BJU international, 114 (3), 354-359

  218. SK Hong, BY Poon, DD Sjoberg, PT Scardino, JA Eastham (2014). “Prostate size and adverse pathologic features in men undergoing radical prostatectomy.” Urology, 84 (1), 153-157

  219. S Carlsson, A Berglund, DD Sjoberg, A Khatami, J Stranne, S Bergdahl, and others (2014). “Effects of surgeon variability on oncologic and functional outcomes in a population-based setting.” BMC urology, 14 (1), 1-8

  220. JE Musser, M Assel, GB Guglielmetti, P Pathak, JL Silberstein, DD Sjoberg, and others (2014). “Impact of routine use of surgical drains on incidence of complications with robot-assisted radical prostatectomy.” Journal of endourology, 28 (11), 1333-1337

  221. KA Moses, LY Chen, DD Sjoberg, M Bernstein, KA Touijer (2014). “Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.” BMC urology, 14, 1-6

  222. SK Hong, E Vertosick, DD Sjoberg, PT Scardino, JA Eastham (2014). “Insignificant disease among men with intermediate-risk prostate cancer.” World journal of urology, 32, 1417-1421

  223. B Ehdaie, PH Dalecki, PT Scardino, JA Eastham, D Amar (2014). “Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study.” Canadian Journal of Anesthesia, 61 (12), 1068

  224. M Rieken, RS Djajadiningrat, LA Kluth, RL Favaretto, E Xylinas, DD Sjoberg, and others (2014). “Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis.” European urology, 66 (5), 811-814

  225. B Ehdaie, DD Sjoberg, PH Dalecki, PT Scardino, JA Eastham, D Amar (2014). “Association entre techniques anesthésiques pour la prostatectomie radicale et récidive biochimique: une étude rétrospective de cohorte.” Canadian Journal of Anesthesia/Journal canadien d’anesthésie, 61, 1068-1074

  226. S Carlsson, M Assel, DD Sjoberg (2014). “L’effet du dépistage du cancer de la prostate, dépend-il du taux du PSA à l’âge de 60 ans?.” Minerva, 13 (10), 123-124

  227. SW Fine, J Chang, JB Poon, DD Sjoberg, HA Al-Ahmadie, YB Chen, and others (2014). “Gleason Score 7 with Tertiary Pattern 5: A Contemporary Analysis.” LABORATORY INVESTIGATION, 94, 227A-228A

  228. J Coleman (2014). “934 Interobserver variability of RENAL, PADUA, and centrality index nephrometry scores.” Eur Urol, 13, e934

  229. AJ Vickers, D Ulmert, DD Sjoberg, CJ Bennette, T Björk, A Gerdtsson, and others (2013). “Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study.” Bmj, 346

  230. BR Cassileth, KJ Van Zee, KS Yeung, MI Coleton, S Cohen, YH Chan, DD Sjoberg, and others (2013). “Acupuncture in the treatment of upper‐limb lymphedema: Results of a pilot study.” Cancer, 119 (13), 2455-2461

  231. M Rink, DJ Lee, M Kent, E Xylinas, HM Fritsche, M Babjuk, A Brisuda, DD Sjoberg, and others (2013). “Predictors of cancer‐specific mortality after disease recurrence following radical cystectomy.” BJU international, 111 (3b), E30-E36

  232. G Deng, Y Chan, DD Sjoberg, A Vickers, KS Yeung, M Kris, D Straus, and others (2013). “Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial.” Supportive Care in Cancer, 21, 1735-1741

  233. A Christensson, C Savage, DD Sjoberg, AM Cronin, M Frank O’Brien, and others (2013). “Association of cancer with moderately impaired renal function at baseline in a large, representative, population‐based cohort followed for up to 30 years.” International journal of cancer, 133 (6), 1452-1458

  234. V Margulis, SF Shariat, Y Rapoport, M Rink, DD Sjoberg, NM Tannir, and others (2013). “Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.” European urology, 63 (5), 947-952

  235. SV Carlsson, LJ Tafe, DC Chade, DD Sjoberg, N Passoni, SF Shariat, and others (2013). “Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.” The Journal of urology, 189 (4), 1314-1319

  236. G Deng, WD Wong, J Guillem, Y Chan, T Affuso, KS Yeung, M Coleton, DD Sjoberg, and others (2013). “A phase II, randomized, controlled trial of acupuncture for reduction of postcolectomy ileus.” Annals of surgical oncology, 20, 1164-1169

  237. JA Forsberg, DD Sjoberg, QR Chen, A Vickers, JH Healey (2013). “Treating metastatic disease: which survival model is best suited for the clinic?.” Clinical Orthopaedics and Related Research®, 471, 843-850

  238. AA Hakimi, L Chen, PH Kim, DD Sjoberg, L Glickman, MR Walker, P Russo (2013). “The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma.” Canadian Urological Association Journal, 7 (11-12), E687

  239. AJ Vickers, DD Sjoberg, DP Ankerst, CM Tangen, PJ Goodman, and others (2013). “The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate‐specific antigen and biopsy outcome.” Cancer, 119 (16), 3007-3011

  240. JL Silberstein, PC Sprenkle, D Su, NE Power, TV Tarin, P Ezell, DD Sjoberg, and others (2013). “Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model.” BJU international, 112 (4), 517

  241. SV Carlsson, MT Peltola, DD Sjoberg, FH Schröder, J Hugosson, and others (2013). “Can one blood draw replace transrectal ultrasonography‐estimated prostate volume to predict prostate cancer risk?.” BJU international, 112 (5), 602-609

  242. KA Touijer, CR Mazzola, DD Sjoberg, PT Scardino, JA Eastham (2013). “Reply to Michael Froehner, Rainer Koch, and Manfred P. Wirth’s letter to the editor re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A ….” European Urology, 65 (2), e25-6

  243. TV Tarin, NE Power, B Ehdaie, JP Sfakianos, JL Silberstein, CJ Savage, DD Sjoberg, and others (2012). “Lymph node–positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.” European urology, 61 (5), 1025-1030

  244. M Rink, DD Sjoberg, E Comploj, V Margulis, E Xylinas, RK Lee, J Hansen, and others (2012). “Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.” Annals of surgical oncology, 19, 4337-4344

  245. M Gustafsson, I Vakili, SEB Keskin, DD Sjoberg, C Larsson (2012). “Optical theorem and forward scattering sum rule for periodic structures.” IEEE transactions on antennas and propagation, 60 (8), 3818-3826

  246. A Sankin, JP Sfakianos, J Schiff, DD Sjoberg, JA Coleman (2012). “Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate.” Urology, 80 (2), 343-346

  247. AJ Vickers, DD Sjoberg, E Basch, F Sculli, M Shouery, V Laudone, and others (2012). “How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy.” European urology, 61 (2), 284

  248. Y Ahallal, K Braun, DD Sjoberg, T Ghoneim, M Esteban, J Mulhall, and others (2012). “Impact des biopsies répétées sur la fonction érectile chez les patients sous surveillance active pour cancer de la prostate.” Progrès en Urologie, 22 (13), 810

  249. M Rink, DD Sjoberg, E Comploj, V Margulis, E Xylinas, R Lee, J Hansen, and others (2012). “Time to Disease Recurrence is a Predictor of Cancer-Specific Mortality After Radical Nephroureterectomy.” UROLOGY, 80 (3), S332-S332

  250. HF Hochberg-Garrett, DM Hoelscher, SV Sharma, DD Sjoberg (2009). “The Skip to Breakfast Project: Development, Implementation, and Evaluation of an Intervention to Increase Healthful Breakfast Consumption among Fifth Grade Students and Their ….” Journal of the American Dietetic Association, 9 (109), A81

  251. D Sjöberg (2006). “Dispersive effective material parameters for Maxwell’s equations.” [Publisher information missing],